{{Rsnum
|rsid=419558
|Gene=DKK2
|Chromosome=4
|position=106922935
|Orientation=plus
|GMAF=0.2828
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=DKK2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 54.9 | 36.3 | 8.8
| HCB | 58.1 | 35.3 | 6.6
| JPT | 38.4 | 46.4 | 15.2
| YRI | 49.3 | 40.4 | 10.3
| ASW | 42.9 | 44.6 | 12.5
| CHB | 58.1 | 35.3 | 6.6
| CHD | 58.3 | 33.3 | 8.3
| GIH | 68.3 | 30.7 | 1.0
| LWK | 27.3 | 49.1 | 23.6
| MEX | 66.7 | 31.6 | 1.8
| MKK | 42.3 | 46.2 | 11.5
| TSI | 52.9 | 37.3 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=19562778
|Title=Wnt antagonist gene polymorphisms and renal cancer
|OA=1
}}

{{PMID Auto
|PMID=20332099
|Title=A systematic gene-based screen of chr4q22-q32 identifies association of a novel susceptibility gene, DKK2, with the quantitative trait of alcohol dependence symptom counts.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}